Galileo Life Sciences, Inc. cancelled the acquisition of Novo Healthnet Limited.

Modern Mobility Aids Inc., formerly Galileo Life Sciences, Inc., is focused on the life sciences and healthcare industry. The Company is focused on acquiring companies within the biopharmaceutical sector, to focus research and development, and to create a manufacturing capacity in the three segments, which include contract research and manufacturing for life sciences companies, drug and device delivery format packaging and strategic development and production alliances. The Company plans to acquire or invest in multiple licensed producers in Canada and the United States. The Company is focused on exploiting the opportunities presented in the medical marijuana arena. The Company's subsidiary is MDRM Group (Canada) Ltd. The Company also focuses on investing in licensed producers in Canada and the United States, as well as suppliers to the industry. The Company has not generated any revenues and had not commenced any revenue generating activities.